MyPeptide sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.

FOXO4-DRI is a D-retro-inverso peptide designed to disrupt the FOXO4-p53 interaction in senescent cells, investigated as a senolytic agent in aging and cellular senescence research.
For laboratory and research use only. Not for human or veterinary use.
The D-retro-inverso modification confers protease resistance. The peptide competitively interferes with FOXO4-p53 binding, selectively inducing apoptosis in senescent cells while sparing proliferating cells in preclinical models.
| sequence | D-retro-inverso FOXO4-p53 interfering peptide |
| molecular Weight | ~5350 Da |
| appearance | White lyophilized powder |
Reconstitute with bacteriostatic water. Handle as a sensitive research peptide.
Lyophilized: −20 °C recommended for long-term. Reconstituted: refrigerate; use promptly.
Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.